Tina Young Poussaint MD

Tina Young Poussaint, MD, FACR

Attending Neuroradiologist; Director of Neurooncologic Imaging; Director, Pediatric Neuroradiology Fellowship; Chair, Boston Children’s Hospital Institutional Review Board; Director, Neuroimaging Center, Pediatric Brain Tumor Consortium

Professor of Radiology, Harvard Medical School

Medical Services

Specialties

  • Neuroradiology
  • Oncologic Imaging

Departments

  • Radiology

Languages

  • English

Programs

  • Neuroradiology
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
To schedule an appointment: Call 617-355-6450
Tina Young Poussaint MD

 

  • Philosophy of care:

I have been inspired by my patients and their families during my career. In particular, my research has focused on the effective care of children through characterization of direct or surrogate imaging markers to improve understanding of physiologic and metabolic profiles of pediatric brain tumors at diagnosis and after therapy.

  • Why I entered medicine:

During college, 2 medicine career exploration projects stimulated me to pursue medicine as my life work. A career in medicine includes my love of science and dedication to helping people. Patient care, teaching and research remain the hallmark of my career.

Experience and Education

Education

Undergraduate

Mount Holyoke College, 1976-1979

South Hadley, MA

Medical School

Yale University School of Medicine, 1979-1983

New Haven, CT

Internship

Yale-New Haven Hospital, 1983-1984

New Haven, CT

Residency

Massachusetts General Hospital, 1984-1987

Boston, MA

Fellowship

Massachusetts General Hospital, 1987-1989

Boston, MA

Certifications

  • Radiology, Neuroradiology

Professional History

Tina Young Poussaint, MD, FACR is Professor of Radiology at Harvard Medical School and at Boston Children’s Hospital has served as an Attending Neuroradiologist. She received her Bachelor of Arts degree from Mount Holyoke College (magna cum laude) where she was elected to the Phi Beta Kappa Society.  She received her MD with honors from Yale University School of Medicine where she was elected to the Alpha Omega Alpha Honor Medical Society. After an internship in pediatrics at Yale-New Haven Hospital (YNHH), she completed residency training in diagnostic radiology and a fellowship in neuroradiology at Massachusetts General Hospital (MGH).  After serving on the neuroradiology faculty at MGH, and she then joined the faculty at Boston Children’s Hospital.  Dr. Poussaint is board-certified in Diagnostic Radiology with a Certificate of Added Qualification in Neuroradiology.

 

Dr. Poussaint also serves as Director of Neuro-oncologic Imaging and as Director of the Pediatric Neuroradiology Fellowship. She is a Fellow of the American College of Radiology (ACR) and has served in several professional organizations including the ASNR, RSNA and SPR. She is a Past-President of the American Society of Pediatric Neuroradiology (ASPNR). Dr. Poussaint is the Chair of the Institutional Review Board of Boston Children’s Hospital.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Salloum R, Hummel TR, Kumar SS, Dorris K, Li S, Lin T, Daryani VM, Stewart CF, Miles L, Poussaint TY, Stevenson C, Goldman S, Dhall G, Packer R, Fisher P, Pollack IF, Fouladi M, Boyett J, Drissi R. A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study. J Neurooncol. 2016 Sep; 129(3):443-51.
  2. Poussaint TY, Vajapeyam S, Ricci KI, Panigrahy A, Kocak M, Kun LE, Boyett JM, Pollack IF, Fouladi M. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol. 2016 May; 18(5):725-34.
  3. Poussaint TY, Huisman TA. Introduction to 'Advances in Pediatric Neuroradiology'. Pediatr Radiol. 2015 Sep; 45 Suppl 3:S369.
  4. Poussaint TY, Panigrahy A, Huisman TA. Pediatric brain tumors. Pediatr Radiol. 2015 Sep; 45 Suppl 3:S443-53.
  5. Kieran MW, Chi S, Goldman S, Onar-Thomas A, Poussaint TY, Vajapeyam S, Fahey F, Wu S, Turner DC, Stewart CF, Moses M, Packer RJ, Jakacki R, Banerjee A, Boyett JM, Fouladi M, Kun L. A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors. Childs Nerv Syst. 2015 Sep; 31(9):1433-45.
  6. Mulkern RV, Ricci KI, Vajapeyam S, Chenevert TL, Malyarenko DI, Kocak M, Poussaint TY. Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom. Acad Radiol. 2015 Mar; 22(3):363-9.
  7. Zukotynski K, Fahey F, Kocak M, Kun L, Boyett J, Fouladi M, Vajapeyam S, Treves T, Poussaint TY. 18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium. J Nucl Med. 2014 Sep; 55(9):1473-80.
  8. Byrd S, Davis B, Gibbs I, Poussaint TY, Simmons VJ. Diversity in diagnostic radiology. Radiology. 2014 Jul; 272(1):301-2.
  9. McCann ME, Schouten AN, Dobija N, Munoz C, Stephenson L, Poussaint TY, Kalkman CJ, Hickey PR, de Vries LS, Tasker RC. Infantile postoperative encephalopathy: perioperative factors as a cause for concern. Pediatrics. 2014 Mar; 133(3):e751-7.
  10. Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Fouladi M, Kun LE. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2014 Jan; 16(2):310-7.
  11. Show all
  12. Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D, Barker FG, Connor S, Evans DG, Fisher MJ, Goutagny S, Harris GJ, Jaramillo D, Karajannis MA, Korf BR, Mautner V, Plotkin SR, Poussaint TY, Robertson K, Shih CS, Widemann BC. Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology. 2013 Nov 19; 81(21 Suppl 1):S33-40.
  13. Fangusaro J, Gururangan S, Poussaint TY, McLendon RE, Onar-Thomas A, Warren KE, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Kun LE, Fouladi M. Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer. 2013 Dec 1; 119(23):4180-7.
  14. Zukotynski KA, Fahey FH, Vajapeyam S, Ng SS, Kocak M, Gururangan S, Kun LE, Poussaint TY. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2013 Aug; 54(8):1237-43.
  15. Brandão LA, Poussaint TY. Pediatric brain tumors. Neuroimaging Clin N Am. 2013 Aug; 23(3):499-525.
  16. Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer. 2013 Sep; 60(9):1397-401.
  17. Li Y, Estroff JA, Khwaja O, Mehta TS, Poussaint TY, Robson CD, Feldman HA, Ware J, Levine D. Callosal dysgenesis in fetuses with ventriculomegaly: levels of agreement between imaging modalities and postnatal outcome. Ultrasound Obstet Gynecol. 2012 Nov; 40(5):522-9.
  18. Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE. A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. J Neurooncol. 2012 Feb; 106(3):643-9.
  19. Paldino MJ, Faerber EN, Poussaint TY. Imaging tumors of the pediatric central nervous system. Radiol Clin North Am. 2011 Jul; 49(4):589-616, v.
  20. Li Y, Estroff JA, Mehta TS, Robertson RL, Robson CD, Poussaint TY, Feldman HA, Ware J, Levine D. Ultrasound and MRI of fetuses with ventriculomegaly: can cortical development be used to predict postnatal outcome? AJR Am J Roentgenol. 2011 Jun; 196(6):1457-67.
  21. Pier DB, Levine D, Kataoka ML, Estroff JA, Werdich XQ, Ware J, Beeghly M, Poussaint TY, Duplessis A, Li Y, Feldman HA. Magnetic resonance volumetric assessments of brains in fetuses with ventriculomegaly correlated to outcomes. J Ultrasound Med. 2011 May; 30(5):595-603.
  22. Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol. 2011 Mar; 13(3):298-306.
  23. Poussaint TY, Kocak M, Vajapeyam S, Packer RI, Robertson RL, Geyer R, Haas-Kogan D, Pollack IF, Vezina G, Zimmerman R, Cha S, Patay Z, Boyett JM, Kun LE. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol. 2011 Apr; 13(4):417-27.
  24. Pollack IF, Stewart CF, Kocak M, Poussaint TY, Broniscer A, Banerjee A, Douglas JG, Kun LE, Boyett JM, Geyer JR. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol. 2011 Mar; 13(3):290-7.
  25. Zukotynski KA, Fahey FH, Kocak M, Alavi A, Wong TZ, Treves ST, Shulkin BL, Haas-Kogan DA, Geyer JR, Vajapeyam S, Boyett JM, Kun LE, Poussaint TY. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2011 Feb; 52(2):188-95.
  26. Li Y, Sansgiri RK, Estroff JA, Mehta TS, Poussaint TY, Robertson RL, Robson CD, Feldman HA, Barnewolt C, Levine D. Outcome of fetuses with cerebral ventriculomegaly and septum pellucidum leaflet abnormalities. AJR Am J Roentgenol. 2011 Jan; 196(1):W83-92.
  27. Prabhu SP, Ng S, Vajapeyam S, Kieran MW, Pollack IF, Geyer R, Haas-Kogan D, Boyett JM, Kun L, Poussaint TY. DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium. Childs Nerv Syst. 2011 Jan; 27(1):11-8.
  28. Senapati GM, Levine D, Smith C, Estroff JA, Barnewolt CE, Robertson RL, Poussaint TY, Mehta TS, Werdich XQ, Pier D, Feldman HA, Robson CD. Frequency and cause of disagreements in imaging diagnosis in children with ventriculomegaly diagnosed prenatally. Ultrasound Obstet Gynecol. 2010 Nov; 36(5):582-95.
  29. Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY. Variability in PET quantitation within a multicenter consortium. Med Phys. 2010 Jul; 37(7):3660-6.
  30. Beeghly M, Ware J, Soul J, du Plessis A, Khwaja O, Senapati GM, Robson CD, Robertson RL, Poussaint TY, Barnewolt CE, Feldman HA, Estroff JA, Levine D. Neurodevelopmental outcome of fetuses referred for ventriculomegaly. Ultrasound Obstet Gynecol. 2010 Apr; 35(4):405-16.
  31. Grace RF, Su H, Sena L, Poussaint TY, Heeney MM, Gutierrez A. Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea. Am J Hematol. 2010 Feb; 85(2):135-7.
  32. Rodriguez DP, Poussaint TY. Imaging of back pain in children. AJNR Am J Neuroradiol. 2010 May; 31(5):787-802.
  33. Kieran MW, Supko JG, Wallace D, Fruscio R, Poussaint TY, Phillips P, Pollack I, Packer R, Boyett JM, Blaney S, Banerjee A, Geyer R, Friedman H, Goldman S, Kun LE, Macdonald T. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer. 2009 Feb; 52(2):169-76.
  34. Saad A, Folkerth R, Poussaint T, Smith E, Ligon K. Meningioangiomatosis associated with meningioma: a case report. Acta Cytol. 2009 Jan-Feb; 53(1):93-7.
  35. Mulkern RV, Forbes P, Dewey K, Osganian S, Clark M, Wong S, Ramamurthy U, Kun L, Poussaint TY. Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium. Acad Radiol. 2008 Sep; 15(9):1099-110.
  36. Levine D, Feldman HA, Tannus JF, Estroff JA, Magnino M, Robson CD, Poussaint TY, Barnewolt CE, Mehta TS, Robertson RL. Frequency and cause of disagreements in diagnoses for fetuses referred for ventriculomegaly. Radiology. 2008 May; 247(2):516-27.
  37. Williams G, Fahey FH, Treves ST, Kocak M, Pollack IF, Boyett JM, Kun LE, Poussaint TY. Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging. 2008 Sep; 35(9):1651-8.
  38. Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol. 2008 Jun; 10(3):341-7.
  39. MacDonald TJ, Stewart CF, Kocak M, Goldman S, Ellenbogen RG, Phillips P, Lafond D, Poussaint TY, Kieran MW, Boyett JM, Kun LE. Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. J Clin Oncol. 2008 Feb 20; 26(6):919-24.
  40. Gururangan S, Turner CD, Stewart CF, O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R, Pollack IF, Blaney SM, Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LE. Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res. 2008 Feb 15; 14(4):1124-30.
  41. Broniscer A, Gururangan S, MacDonald TJ, Goldman S, Packer RJ, Stewart CF, Wallace D, Danks MK, Friedman HS, Poussaint TY, Kun LE, Boyett JM, Gajjar A. Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6712-8.
  42. Poussaint TY, Phillips PC, Vajapeyam S, Fahey FH, Robertson RL, Osganian S, Ramamurthy U, Mulkern RV, Treves ST, Boyett JM, Kun LE. The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR Am J Neuroradiol. 2007 Apr; 28(4):603-7.
  43. Liu AK, Marcus KJ, Fischl B, Grant PE, Poussaint TY, Rivkin MJ, Davis P, Tarbell NJ, Yock TI. Changes in cerebral cortex of children treated for medulloblastoma. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):992-8.
  44. Marcus KJ, Astrakas LG, Zurakowski D, Zarifi MK, Mintzopoulos D, Poussaint TY, Anthony DC, De Girolami U, Black PM, Tarbell NJ, Tzika AA. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol. 2007 Mar; 30(3):651-7.
  45. Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol. 2007 Apr; 9(2):145-60.
  46. Rodriguez DP, Poussaint TY. Neuroimaging of the child with developmental delay. Top Magn Reson Imaging. 2007 Feb; 18(1):75-92.
  47. Levine D, Cavazos C, Kazan-Tannus JF, McKenzie CA, Dialani V, Robson CD, Robertson RL, Poussaint TY, Busse RF, Rofsky NM. Evaluation of real-time single-shot fast spin-echo MRI for visualization of the fetal midline corpus callosum and secondary palate. AJR Am J Roentgenol. 2006 Dec; 187(6):1505-11.
  48. Fouladi M, Blaney SM, Poussaint TY, Freeman BB, McLendon R, Fuller C, Adesina AM, Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar A. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Cancer. 2006 Nov 1; 107(9):2291-7.
  49. Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol. 2007 Mar; 82(1):95-101.
  50. Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, Bomgaars L, Blaney SM, Kun LE, Boyett JM. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res. 2006 Mar 1; 12(5):1540-6.
  51. Poussaint TY, Rodriguez D. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy. Neuroimaging Clin N Am. 2006 Feb; 16(1):169-92, ix.
  52. Anselm IA, Anselm IM, Alkuraya FS, Salomons GS, Jakobs C, Fulton AB, Mazumdar M, Rivkin M, Frye R, Poussaint TY, Marsden D. X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis. 2006 Feb; 29(1):214-9.
  53. Baser ME, Poussaint TY. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. J Med Genet. 2006 Mar; 43(3):285-7.
  54. Fleischman A, Brue C, Poussaint TY, Kieran M, Pomeroy SL, Goumnerova L, Scott RM, Cohen LE. Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. Pediatrics. 2005 Jun; 115(6):e742-8.
  55. Lim R, Jaramillo D, Poussaint TY, Chang Y, Korf B. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1. AJR Am J Roentgenol. 2005 Mar; 184(3):962-8.
  56. Zacharia TT, Jaramillo D, Poussaint TY, Korf B. MR imaging of abdominopelvic involvement in neurofibromatosis type 1: a review of 43 patients. Pediatr Radiol. 2005 Mar; 35(3):317-22.
  57. Sun Y, Schmidt NO, Schmidt K, Doshi S, Rubin JB, Mulkern RV, Carroll R, Ziu M, Erkmen K, Poussaint TY, Black P, Albert M, Burstein D, Kieran MW. Perfusion MRI of U87 brain tumors in a mouse model. Magn Reson Med. 2004 May; 51(5):893-9.
  58. Rodriguez D, Young Poussaint T. Neuroimaging findings in neurofibromatosis type 1 and 2. Neuroimaging Clin N Am. 2004 May; 14(2):149-70, vii.
  59. Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer. 2004 Mar 15; 100(6):1246-56.
  60. Caruso PA, Poussaint TY, Tzika AA, Zurakowski D, Astrakas LG, Elias ER, Bay C, Irons MB. MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome. Neuroradiology. 2004 Jan; 46(1):3-14.
  61. Heath JA, Turner CD, Poussaint TY, Scott RM, Goumnerova L, Kieran MW. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience. Pediatr Hematol Oncol. 2003 Oct-Nov; 20(7):497-504.
  62. Jaramillo D, Poussaint TY, Grottkau BE. Scoliosis: evidence-based diagnostic evaluation. Neuroimaging Clin N Am. 2003 May; 13(2):335-41, xii.
  63. Poussaint TY, Jaramillo D, Chang Y, Korf B. Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas. AJR Am J Roentgenol. 2003 Feb; 180(2):419-23.
  64. Zarifi MK, Astrakas LG, Poussaint TY, Plessis Ad Ad, Zurakowski D, Tzika AA. Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia. Radiology. 2002 Dec; 225(3):859-70.
  65. Poussaint TY, Moeller KK. Imaging of pediatric head trauma. Neuroimaging Clin N Am. 2002 May; 12(2):271-94, ix.
  66. Faerber EN, Poussaint TY. Magnetic resonance of metabolic and degenerative diseases in children. Top Magn Reson Imaging. 2002 Feb; 13(1):3-21.
  67. Poussaint TY, Moeller K. Pediatric Head Trauma. Neuroimaging Clin No Am. 2002; In Press.
  68. Faerber EN, Poussaint TY. MR of Metabolic and Degenerative Disease in Childhood. Topics in MRI. 2002.
  69. O'Tuama LA, Poussaint TY. Thallium-201 single-photon emission CT in recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 2002 Jan; 23(1):174-5.
  70. Poussaint TY. Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging. 2001 Dec; 12(6):411-33.
  71. Poussaint TY. Magnetic resonance imaging (MRI) is one of the most important imaging modalities in pediatric neuroradiology. Top Magn Reson Imaging. 2001 Dec; 12(6):359.
  72. Poussaint, TY. Editorial. Topics in MRI. 2001; 359.
  73. Poussaint, TY. MR Imaging of Pediatric Brain Tumors: State of the Art. Topics in MRI. 2001; 12: 411-433.
  74. O'Tuama LA,Poussaint TY. Thallum-201 Single-Proton Emission CT versus CT for the Detection of Recurrent Squamous Cell Carcinoma of the Head and Neck. AJNR Am J Neuroradiol. 2001; 22(1).
  75. Madsen JR, Poussaint TY, Barnes PD. Congenital Malformations of the Cerebellum and Posterior Fossa: Radiographic Diagnosis and Surgical Treatment. . The Cerebellum and Its Disorders. 2001.
  76. Young Poussaint T and Barnes PD. Imaging of the Developmentally Delayed Child. Magnetic Resonance Imaging Clinics of North America. 2001; 999-119.
  77. Zarifi MK, Tzika AA, Astrakas LG, Poussaint TY, Anthony DC, Darras BT. Magnetic resonance spectroscopy and magnetic resonance imaging findings in Krabbe's disease. J Child Neurol. 2001 Jul; 16(7):522-6.
  78. Tzika AA, Zurakowski D, Poussaint TY, Goumnerova L, Astrakas LG, Barnes PD, Anthony DC, Billett AL, Tarbell NJ, Scott RM, Black PM. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology. 2001 Feb; 43(2):169-77.
  79. Poussaint TY, Fox JW, Dobyns WB, Radtke R, Scheffer IE, Berkovic SF, Barnes PD, Huttenlocher PR, Walsh CA. Periventricular nodular heterotopia in patients with filamin-1 gene mutations: neuroimaging findings. Pediatr Radiol. 2000 Nov; 30(11):748-55.
  80. Caruso P, Poussaint TY. Case Report: Supratentorial intraventricular PNET. ACR Learning File CD-ROM Series. 2000.
  81. Caruso P, Poussaint TY. Case Report: Supratentorial ependymoma. ACR Learning File CD-ROM Series. 2000.
  82. Drubach LA, Connolly LP, Poussaint TY, Faul PN, Treves ST. Role of intraoperative skeletal scintigraphy in the localization of osteoblastomas. Clin Nucl Med. 2000 Oct; 25(10):819-20.
  83. Siffert J, Poussaint TY, Goumnerova LC, Scott RM, LaValley B, Tarbell NJ, Pomeroy SL. Neurological dysfunction associated with postoperative cerebellar mutism. J Neurooncol. 2000 May; 48(1):75-81.
  84. Poussaint, TY. Neuroradiology portion of Pediatric Radiology Chapter . Mosby Yearbook. 1999.
  85. Young Poussaint T, Yousuf N, Barnes PD, Anthony DC, Zurakowski D, Scott RM, Tarbell NJ. Cervicomedullary astrocytomas of childhood: clinical and imaging follow-up. Pediatr Radiol. 1999 Sep; 29(9):662-8.
  86. Santiago Medina L, al-Orfali M, Zurakowski D, Poussaint TY, DiCanzio J, Barnes PD. Occult lumbosacral dysraphism in children and young adults: diagnostic performance of fast screening and conventional MR imaging. Radiology. 1999 Jun; 211(3):767-71.
  87. Korf BR, Schneider G, Poussaint TY. Structural anomalies revealed by neuroimaging studies in the brains of patients with neurofibromatosis type 1 and large deletions. Genet Med. 1999 May-Jun; 1(4):136-40.
  88. Poussaint TY, Gudas T, Barnes PD. Imaging of neuroendocrine disorders of childhood. Neuroimaging Clin N Am. 1999 Feb; 9(1):157-75.
  89. Kim FM, Poussaint TY, Barnes PD. Neuroimaging of scoliosis in childhood. Neuroimaging Clin N Am. 1999 Feb; 9(1):195-221.
  90. Oestreich AE, Young LW, Poussaint TY. Scoliosis circa 2000: radiologic imaging perspective. II. Treatment and follow-up. Skeletal Radiol. 1998 Dec; 27(12):651-6.
  91. Oestreich AE, Young LW, Young Poussaint T. Scoliosis circa 2000: radiologic imaging perspective. I. Diagnosis and pretreatment evaluation. Skeletal Radiol. 1998 Nov; 27(11):591-605.
  92. O'Tuama LA, Poussaint TY, Anthony DC, Treves ST. Childhood brain tumor: neuroimaging correlated with disease outcome. Pediatr Neurol. 1998 Oct; 19(4):259-62.
  93. Madsen JR, Vallat AV, Poussaint TY, Scott RM, De Girolami U, Anthony DC. Focal cortical dysplasia with glioproliferative changes causing seizures: report of 3 cases. Pediatr Neurosurg. 1998 May; 28(5):261-6.
  94. Poussaint TY, Kowal JR, Barnes PD, Zurakowski D, Anthony DC, Goumnerova L, Tarbell NJ. Tectal tumors of childhood: clinical and imaging follow-up. AJNR Am J Neuroradiol. 1998 May; 19(5):977-83.
  95. Medina LS, Zurakowski D, Strife KR, Robertson RL, Poussaint TY, Barnes PD. Efficacy of fast screening MR in children and adolescents with suspected intracranial tumors. AJNR Am J Neuroradiol. 1998 Mar; 19(3):529-34.
  96. Poussaint TY, Barnes PD, Nichols K, Anthony DC, Cohen L, Tarbell NJ, Goumnerova L. Diencephalic syndrome: clinical features and imaging findings. AJNR Am J Neuroradiol. 1997 Sep; 18(8):1499-505.
  97. Robertson RL, Burrows PE, Barnes PD, Robson CD, Poussaint TY, Scott RM. Angiographic changes after pial synangiosis in childhood moyamoya disease. AJNR Am J Neuroradiol. 1997 May; 18(5):837-45.
  98. Poussaint TY, Ball WS, Jr., Barnes PD. Imaging of the spine and spinal cord. Practical pediatric imaging. Diagnostic radiology of infants and children. 1997; 259-325..
  99. Barnes PD, Robertson RL, Young Poussaint T. Structural imaging of CNS tumors. Cancer of the nervous system. 1997; 54-97.
  100. Poussaint TY, Barnes PD, Anthony DC, Spack N, Scott RM, Tarbell NJ. Hemorrhagic pituitary adenomas of adolescence. AJNR Am J Neuroradiol. 1996 Nov-Dec; 17(10):1907-12.
  101. Levy HL, Lobbregt D, Barnes PD, Poussaint TY. Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring. J Pediatr. 1996 Jun; 128(6):770-5.
  102. Steingard RJ, Renshaw PF, Yurgelun-Todd D, Appelmans KE, Lyoo IK, Shorrock KL, Bucci JP, Cesena M, Abebe D, Zurakowski D, Poussaint TY, Barnes P. Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry. 1996 Mar; 35(3):307-11.
  103. Barnes PD, Robson CD, Robertson RL, Poussaint TY. Pediatric orbital and visual pathway lesions. Neuroimaging Clin N Am. 1996 Feb; 6(1):179-98.
  104. Poussaint TY, Siffert J, Barnes PD, Pomeroy SL, Goumnerova LC, Anthony DC, Sallan SE, Tarbell NJ. Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol. 1995 Apr; 16(4):693-9.
  105. Chiang V, Adelson PD, Poussaint TY, Hand M, Churchwell KB. Brain abscesses caused by Clostridium septicum as a complication of hemolytic-uremic syndrome. Pediatr Infect Dis J. 1995 Jan; 14(1):72-4.
  106. Woods BT, Brennan S, Yurgelun-Todd D, Young T, Panzarino P. MRI abnormalities in major psychiatric disorders: an exploratory comparative study. J Neuropsychiatry Clin Neurosci. 1995; 7(1):49-53.
  107. Barnes PD, Young Poussaint T, Robertson RL. Imaging of the pediatric spine and spinal neuraxis. Spine: state of the art reviews. Spinal imaging. 1995; 73-92.
  108. Appignani BA, Jaramillo D, Barnes PD, Poussaint TY. Dysraphic myelodysplasias associated with urogenital and anorectal anomalies: prevalence and types seen with MR imaging. AJR Am J Roentgenol. 1994 Nov; 163(5):1199-203.
  109. Barnes PD, Poussaint TY, Burrows PE. Imaging of pediatric central nervous system infections. Neuroimaging Clin N Am. 1994 May; 4(2):367-91.
  110. Barnes P, Poussaint TY, Burrows PE. Imaging of pediatric CNS infections. Neuroimaging Clin No Am. 1994; 4:367-91.
  111. Johnson LA, Pearlman JD, Miller CA, Young TI, Thulborn KR. MR quantification of cerebral ventricular volume using a semiautomated algorithm. AJNR Am J Neuroradiol. 1993 Nov-Dec; 14(6):1373-8.
  112. Lopez-Bresnahan MV, Kearse LA, Yanez P, Young TI. Anterior communicating artery collateral flow protection against ischemic change during carotid endarterectomy. J Neurosurg. 1993 Sep; 79(3):379-82.
  113. Strand RD, Barnes PD, Poussaint TY, Estroff JA, Burrows PE. Cystic retrocerebellar malformations: unification of the Dandy-Walker complex and the Blake's pouch cyst. Pediatr Radiol. 1993; 23(4):258-60.
  114. Young TI. MR and CT imaging in multiple sclerosis. Current practice in radiology. 1993; 502-511.
  115. Young TI. Magnetic resonance imaging of spine.[Book Review]. Year Book Med Pub. 1991; 75:666.
  116. Teitelbaum GP, Lin MC, Watanabe AT, Norfray JF, Young TI, Bradley WG. Ferromagnetism and MR imaging: safety of carotid vascular clamps. AJNR Am J Neuroradiol. 1990 Mar-Apr; 11(2):267-72.
  117. Smith CG, Paradise JL, Young TI. Modified schema for classifying positive-pressure tympanograms. Pediatrics. 1982 Mar; 69(3):351-4.
  118. Greene MH, Young TI, Clark WH. Malignant melanoma in renal-transplant recipients. Lancet. 1981 May 30; 1(8231):1196-9.
  119. Greene MH, Young TI. Polyethylene glycol in suppositories: carcinogenic? Ann Intern Med. 1980 Nov; 93(5):781.
  120. Tzika AA, Astrakas LG, Kieran M, Zurakowski D, Zarifi MK, Poussaint T. Choline to N-Acetylaspartate Ratio is Predictive of Pediatric BrainTumor Progression .
  121. Tzika AA, Zarifi MK, Goumnerova L, Astrakas LG, Zurakowski D, Poussaint TY, Anthony DA, Scott RM, Black PM . Neuroimaging of Pediatric Brain Tumors: Gd-DTPA Enhanced, Hemodynamic and Diffusion MR Imaging Compared to MR Spectroscopic Imaging. . AJNR, In Press.
  122. Astrakas L, Tzika A, Poussaint T, Kieran M. MRSI of Antiangiogenesis/Radiation in Pediatric Gliomas .
  123. Zarifi M, Astrakas L, Zurakowski D, Poussaint T, duPlessis A, Tzika A . Predicting Clinical Outcome in Perinatal Asphyxia by MRI and MRS.
  124. Poussaint TY, Caruso P, Anthony D, Connolly L, Kim F, Riviello J. Rasmussen Encephalitis: typical and atypical MRI findings with pathologic correlation.
  125. Zarifi M, Astrakas L, Zurakowski D, Poussaint T, Duplessis A, Tzika A . Predicting Clinical Outcome in Infants with Perinatal Asphyxia.
  126. Zarifi M, Astrakas L, Zurakowski D, Poussaint T, duPlessis A, Tzika A . Predicting Clinical Outcome in Perinatal Asphyxia by MRI and MRS.
  127. Zarifi M, Astrakas L, Zurakowski D, Poussaint T, Duplessis A, Tzika A . Predicting Clinical Outcome in Infants with Perinatal Asphyxia.
  128. Tzika A, Cheng L, Astrakas L, Zarifi M, Poussaint T, Goumnerova L, Zurakowski D, Anthony D, Gonzalez G. . Comparison of in Vivo proton MRS of pediatric brain tumors with ex vivo Magic Angle Spinning MRS of intact biopsy tumor samples .
  129. Astrakas L, Tzika A, Poussaint T, Kieran M. MRSI of Antiangiogenesis/Radiation in Pediatric Gliomas.
  130. Poussaint TY, Caruso P, Anthony D, Connolly L, Kim F, Riviello . Rasmussen Encephalitis: typical and atypical MRI findings with pathologic correlation.
  131. Poussaint TY, Tzika AA, Caruso P, Astrakas L, Elias ER, Irons M. . MR Imaging and MR Spectroscopy Findings in Smith-Lemli-Opitz Syndrome.
  132. Poussaint TY, Tzika AA, Caruso P, Astrakas L, Elias ER, Irons M. MR Imaging and MR Spectroscopy Findings in Smith-Lemli-Opitz Syndrome.
  133. Tzika AA, Astrakas LG, Kieran M, Zurakowski D, Zarifi MK, Poussaint T. Choline to N-Acetylaspartate Ratio is Predictive of Pediatric Brain Tumor Progression.
  134. Tzika A, Cheng L, Astrakas L, Zarifi M, Poussaint T, Goumnerova L, Zurakowski D, Anthony D, Gonzalez G . Comparison of in Vivo proton MRS of pediatric brain tumors with ex vivo Magic Angle Spinning MRS of intact biopsy tumor samples .
To schedule an appointment: Call 617-355-6450

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close